MedPath

Evaluation of the effect of larval source management and housing improvement when added to an existing malaria control strategy

Not Applicable
Recruiting
Conditions
Malaria
Registration Number
PACTR201604001501493
Lead Sponsor
Wageningen University and Research Centre
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
6480
Inclusion Criteria

All villages in the demarcated study site will initially be eligible for full participation in the trial. All households in trial villages will be eligible for entomological and epidemiological monitoring to assess trial outcomes. Within these households, children aged 6 to 59 months with informed consent from a guardian will be eligible for assessing parasitemia.

Exclusion Criteria

A buffer zone around each trial village, necessary for preventing contamination bias, will lead to the exclusion of some villages in the study site from the trial. This will be kept to a minimum, and done randomly by applying a spatial restriction to the village selection procedure.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Entomological inoculation rate;Prevalence of anaemia in children aged 6-59 months
Secondary Outcome Measures
NameTimeMethod
Malaria vector community composition;Malaria vector human blood index;Peak malaria vector biting time;Larval mosquito density;Parasite prevalence in children aged 6-59 months;Incidence of clinical malaria in children aged 6-59 months
© Copyright 2025. All Rights Reserved by MedPath